SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-04-019256
Filing Date
2004-10-04
Accepted
2004-10-04 14:18:20
Documents
1
Period of Report
2004-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 3862
  Complete submission text file 0001179110-04-019256.txt   5695
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address EYETECH PHARMACEUTICALS INC 500 SEVENTH AVE. NEW YORK NY 10018
MULLEN MICHAEL (Reporting) CIK: 0001277482 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 041061799